Close menu




Comments

Photo credits: pixabay.com

Commented by Mario Hose on July 3rd, 2023 | 07:30 CEST

Better than Nvidia and Apple? Up to 150% price potential beckons for aifinyo, sdm and HelloFresh

  • Technology
  • Fintech
  • security
  • smallcaps

Those who have bet on Big Tech companies this year are delighted with the high price gains. But haven't Nvidia, Apple, and even some DAX stocks run hot? A repeat performance like in the first half of 2023 is rather unlikely. Taking part of the profits is a good idea. And as a new investment, a whole range of companies are "still" in the shadow of Big Tech and AI hype. It is exactly here where there is also an opportunity. Today, we look at small and mid-caps where analysts say there is over 100% upside. Take aifinyo, for example. The B2B fintech published strong numbers for 2022 and the start of 2023 was also promising. sdm has also had a good start to the current year. Due to two acquisitions, revenue and profit are expected to multiply in the current year.

Read

Commented by André Will-Laudien on June 30th, 2023 | 07:30 CEST

Doublers are possible! Bayer, Defence Therapeutics, BioNTech, Valneva - It is hard to believe!

  • Biotechnology
  • Cancer
  • Pharma

In 2022, a total of 19.5 million people received the shocking diagnosis of "cancer". Current trends, unfortunately, suggest that this number will continue to rise in the coming years. However, thanks to growing research successes, there is hope that biotechnology will significantly increase the chances of survival for those affected. It is a matter of developing suitable active substances and launching modern therapies. mRNA technology has recently made a name for itself in cancer prevention. Innovative biotech companies are back on the radar of risk-conscious investors. We are on the lookout for doubling potential.

Read

Commented by André Will-Laudien on June 29th, 2023 | 08:50 CEST

100% with Clean Energy! BYD, Regenx Technologies, BASF, Siemens Energy - Recycling is becoming a challenge!

  • Metals
  • recycling
  • Electromobility

As Western governments finally take climate protection seriously, the media has focused on the areas of energy, mobility, and health. It is clear to all participants that the changes in the world's climate will lead to undesirable developments. Glaciers are melting, the Earth's temperature is rising, and our oceans are already too warm for many species. Huge investments are being made in renewable power generation and modern mobility solutions. The high growth requires access to metals. Recycling also plays a major role because it conserves valuable resources and brings raw materials back into the cycle. Some companies are making a name for themselves, and shareholders can benefit from this.

Read

Commented by Fabian Lorenz on June 29th, 2023 | 08:10 CEST

Change of favorites in hydrogen shares! ThyssenKrupp instead of Nel ASA? Can Grid Metals take off?

  • Mining
  • Metals
  • Hydrogen
  • renewableenergies

Is there a shift in favorites among hydrogen stocks? It certainly seems that way. While former favorites Nel ASA and Plug Power are struggling, ThyssenKrupp is making a strong entry with the IPO of Nucera. The subscription period for the hydrogen subsidiary has been running since Friday, and demand already exceeds supply. In contrast, Nel ASA and Plug Power are being left behind. The Danes, in particular, are facing technical chart challenges and are struggling to maintain the EUR 1 mark. But perhaps the hype around Nucera is an entry opportunity for the established hydrogen specialists. And what about lithium? Stocks such as Standard Lithium and Alkem have been trending nicely in recent weeks. Grid Metals has yet to gain momentum, despite plans to process lithium as early as 2024.

Read

Commented by Nico Popp on June 29th, 2023 | 07:50 CEST

Hydrogen abc - Everything about opportunities and risks: ThyssenKrupp, Daimler Truck, First Hydrogen

  • Hydrogen
  • fuelcell
  • renewableenergies
  • greenhydrogen

Hydrogen is experiencing a boom. The upcoming IPO of ThyssenKrupp subsidiary Nucera has a signal effect. At the beginning of the subscription period, the demand for the shares of the hydrogen specialist exceeded the supply. The shares are to be traded for the first time on July 5. Here we will discuss what Nucera's IPO means for the industry and where risks and opportunities lurk.

Read

Commented by Stefan Feulner on June 29th, 2023 | 07:30 CEST

The profiteers of the new super cycles - SAP, Defense Metals, Hut 8 Mining

  • Mining
  • RareEarths
  • Tungsten
  • AI

Every new innovation takes time and is also not protected from delays. This can be clearly seen in the example of listed renewable energy companies. At the beginning of the new decade, these companies were praised with great anticipation, but disillusionment quickly set in due to the lack of sales and profits. On the other hand, the fact that this sector will prevail in the long term due to the energy turnaround is a foregone conclusion. The situation is similar for artificial intelligence and blockchain technology.

Read

Commented by Fabian Lorenz on June 28th, 2023 | 08:05 CEST

Hydrogen vs battery shares: From Plug Power to Standard Lithium and Power Nickel?

  • Mining
  • Nickel
  • Lithium
  • Electromobility
  • fuelcell

Who does the future belong to? Hydrogen or battery technology? The truth likely lies somewhere in the middle, and both technologies will find their place. However, it is clear that batteries currently have the upper hand in the context of electromobility. This can also be seen in the stock market. While companies like Nel ASA and Plug Power are struggling, Tesla, BYD & Co. are celebrating record sales. But success is heavily dependent on the supply of raw materials. Lithium and nickel are scarce and in high demand. Standard Lithium and Power Nickel are among the profiteers. Standard Lithium is recommended as a buy by analysts with around 100% price potential. Power Nickel has again published promising drill results, which could multiply the upcoming resource estimate. Plug Power is currently overshadowed by the Nucera IPO, but there is some interesting news.

Read

Commented by Armin Schulz on June 28th, 2023 | 07:20 CEST

Barrick Gold, Desert Gold, Lanxess - After setbacks, is now a good time to buy?

  • Mining
  • Gold

An old merchant's rule states: The profit lies in the purchase. This wisdom can also be applied to stock market trading. As an investor, waiting for a setback before buying is always advisable. This avoids the danger of entering at a high. After the start of the banking crisis, the gold price soared, and those who bought then are now at a disadvantage. With the recent decline in the gold price, there may be an interesting opportunity to enter the market again. We, therefore, take a look at two gold companies. Finally, we will analyze Lanxess, whose shares recently suffered heavy losses.

Read

Commented by Nico Popp on June 28th, 2023 | 07:00 CEST

Bank shock and gold trickery: Deutsche Bank, Commerzbank, Globex Mining

  • Mining
  • Commodities
  • Banking

Stress can be positive. That is when it sharpens our senses and is part of a constructive process. To be prepared for stress, banks undergo so-called stress tests. As the European banking supervisory authority has now reported, institutions must be prepared for negative surprises - the consequences for shareholders and customers are likely to be noticeable. We explain the situation and present alternatives.

Read

Commented by Armin Schulz on June 26th, 2023 | 09:20 CEST

Bayer, BioNxt Solutions, BioNTech - Biotech facing a rebound?

  • Biotechnology

Due to the Corona pandemic, the pharmaceutical and biotech sector received a lot of attention. Many investors invested too late and could hardly benefit from the significant upward movements. After the hype, a sense of disillusionment set in. The vaccine manufacturers felt the effects because as soon as the pandemic subsided, the stock market also went down. Large and small companies experienced sell-offs, with some trading below their cash reserves. These low prices led to a wave of takeovers. Most recently, Novartis snapped up the biotech company Chinook for up to USD 3.5 billion. Therefore, today, we look at three companies from the healthcare sector.

Read